摘要
目的:观察糜蛋白酶溶液联合氨溴索雾化吸入对老慢支急发患者的疗效。方法:在综合治疗的基础上,治疗组给予糜蛋白酶联合氨溴索雾化吸入,对照组给予氨溴索雾化吸入。结果:对照组总有效率为75.0%,治疗组总有效率为97.5%,治疗组明显优于对照组(P<0.05)。结论:雾化吸入治疗老慢支急发作,糜蛋白酶联合氨溴索雾化吸入优于单纯氨溴索治疗。
ABSTRACT Objective： To observe the efficacy of chymotrypsin combined with ambroxol inhalation therapy in 80 patients with acute exacerbations of chronic bronchitis. Methods： The patients admitted to the emergency department were randomly assigned to either a treatment group or a control group, in which chymotrypsin in combination with ambroxol inhalation or only atomizing ambroxol inhalation （hydrochloride） were respectively given on the basis of the comprehensive treatment. Results： The total efficiency was 97.5% in the treatment group and 75% in the control group. The between-group difference is statistically significant （P〈0.05）. Conclusion： Chymotrypsin in combination with ambroxol inhalation can significantly improve the clinical efficacy in patients with acute exacerbations of chronic bronchitis. KEY WORDS chymotrypsin; ambroxol; atomizing inhalation; chronic bronchitis
出处
《上海医药》
CAS
2013年第5期26-28,共3页
Shanghai Medical & Pharmaceutical Journal
关键词
糜蛋白酶
氨溴索
雾化吸入
慢性支气管炎
chymotrypsin
ambroxol
atomizing inhalation
chronic bronchitis
